Loading clinical trials...
Loading clinical trials...
The main aim of this study is to collect real-world longitudinal data on participants with β-thalassemia treated with betibeglogene autotemcel (beti-cel) in the post marketing setting. To assess the l...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Genetix Biotherapeutics Inc.
Collaborators
NCT06647979 · Sickle Cell Disease, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0), and more
NCT04143724 · Beta-Thalassemia
NCT06308159 · Beta-Thalassemia
NCT04064060 · Myelodysplastic Syndromes (MDS), Beta-thalassemia, and more
NCT03653338 · Sickle Cell Anemia, Beta-thalassemia Major, and more
UCSF Benioff Children's Hospitals
Oakland, California
Stanford University
Palo Alto, California
University of Minnesota
Minneapolis, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions